Segui
Gianluigi Forloni
Gianluigi Forloni
Head of Neuroscience Department IRCCS Mario Negri, Milan
Email verificata su marionegri.it
Titolo
Citata da
Citata da
Anno
Neurotoxicity of a prion protein fragment
G Forloni, N Angeretti, R Chiesa, E Monzani, M Salmona, O Bugiani, ...
Nature 362 (6420), 543-546, 1993
11451993
Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein
C Balducci, M Beeg, M Stravalaci, A Bastone, A Sclip, E Biasini, L Tapella, ...
Proceedings of the National Academy of Sciences 107 (5), 2295-2300, 2010
5812010
Full length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects
R Borghi, R Marchese, A Negro, L Marinelli, G Forloni, D Zaccheo, ...
Neuroscience letters 287 (1), 65-67, 2000
4782000
Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia
P Quadri, C Fragiacomo, R Pezzati, E Zanda, G Forloni, M Tettamanti, ...
The American journal of clinical nutrition 80 (1), 114-122, 2004
4652004
Apoptosis mediated neurotoxicity induced by chronic application of β amyloid fragment 25–35
G Forloni, R Chiesa, S Smiroldo, L Verga, M Salmona, F Tagliavini, ...
Neuroreport 4 (5), 523-526, 1993
4231993
Sporadic human prion diseases: molecular insights and diagnosis
G Puoti, A Bizzi, G Forloni, JG Safar, F Tagliavini, P Gambetti
The Lancet Neurology 11 (7), 618-628, 2012
3982012
Frontotemporal dementia and its subtypes: a genome-wide association study
R Ferrari, DG Hernandez, MA Nalls, JD Rohrer, A Ramasamy, JBJ Kwok, ...
The Lancet Neurology 13 (7), 686-699, 2014
3672014
The prevalence of mild cognitive impairment in diverse geographical and ethnocultural regions: The COSMIC Collaboration
Perminder, Sachdev S
Plos One 10 (11), e0142388, 2015
3562015
Long‐term acetyl‐L‐carnitine treatment in Alzheimer's disease
A Spagnoli, U Lucca, G Menasce, L Bandera, G Cizza, G Forloni, ...
Neurology 41 (11), 1726-1726, 1991
3491991
Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1
G Forloni, F Demicheli, S Giorgi, C Bendotti, N Angeretti
Molecular brain research 16 (1-2), 128-134, 1992
3101992
Anti-amyloidogenic activity of tetracyclines: studies in vitro
G Forloni, L Colombo, L Girola, F Tagliavini, M Salmona
FEBS letters 487 (3), 404-407, 2001
3012001
JNK signalling: a possible target to prevent neurodegeneration
T Borsello, G Forloni
Current pharmaceutical design 13 (18), 1875-1886, 2007
2902007
Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro.
F Tagliavini, F Prelli, L Verga, G Giaccone, R Sarma, P Gorevic, B Ghetti, ...
Proceedings of the National Academy of Sciences 90 (20), 9678-9682, 1993
2901993
The SIRT1 activator resveratrol protects SK‐N‐BE cells from oxidative stress and against toxicity caused by α‐synuclein or amyloid‐β (1‐42) peptide
D Albani, L Polito, S Batelli, S De Mauro, C Fracasso, G Martelli, ...
Journal of neurochemistry 110 (5), 1445-1456, 2009
2882009
Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and β-amyloid production in cultures
R Del Bo, N Angeretti, E Lucca, MG De Simoni, G Forloni
Neuroscience letters 188 (1), 70-74, 1995
2701995
TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers
N Finch, MM Carrasquillo, M Baker, NJ Rutherford, G Coppola, ...
Neurology 76 (5), 467-474, 2011
2582011
Evaluation of quinacrine treatment for prion diseases
A Barret, F Tagliavini, G Forloni, C Bate, M Salmona, L Colombo, ...
Journal of virology 77 (15), 8462-8469, 2003
2522003
Tetracyclines affect prion infectivity
G Forloni, S Iussich, T Awan, L Colombo, N Angeretti, L Girola, I Bertani, ...
Proceedings of the National Academy of Sciences 99 (16), 10849-10854, 2002
2342002
Effectiveness of anthracycline against experimental prion disease in Syrian hamsters
F Tagliavini, RA McArthur, B Canciani, G Giaccone, M Porro, M Bugiani, ...
Science 276 (5315), 1119-1121, 1997
2341997
Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein
C Selvaggini, L Degioia, L Cantu, E Ghibaudi, L Diomede, F Passerini, ...
Biochemical and biophysical research communications 194 (3), 1380-1386, 1993
2331993
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20